When thalidomide came to market in the 1950s as a morning sickness treatment, no one imagined the many cases of birth defects that would result from use of the drug. More than 50 years later, a small Madison-based stem cell company is selling a research product that could have prevented what some have called one of the biggest medical tragedies of modern times. Read full Journal Sentinel story here.
- InsideWis: Colorado’s state brand has some deep Badger rootsNovember 15, 2018
- Wisconsin State Journal: Blexx, a startup whose tool destroys used hypodermic needles, wins Madison pitch contest.November 9, 2018
- WisBusiness: Elevator Pitch Olympics features life science startupsNovember 9, 2018
- Kelly Lietz on LinkedIn: Identifying Win-Win Opportunities in Startup InvestingNovember 9, 2018
- InsideWis: Tech, art and design of ‘smart’ cities converge through Wisconsin companyNovember 6, 2018